Post-translational modifications of proteins in malignant transformation and tumor maintenance of pancreatic ductal adenocarcinoma (PDAC) in the context of KRAS signaling remain poorly understood. The gene discussed is KRAS; the disease is pancreatic ductal adenocarcinoma.